Skip to content

Lovelace Biomedical Research Institute government contracts

$97.8M obligated across 20 federal awards. 9 are still running.

UEI MBT9RXJJ7428Latest award Sep 14, 2026

Who buys from Lovelace Biomedical Research Institute

AgencyAwardsObligated
Food and Drug Administration6$56.1M
National Institutes of Health11$27.3M
Office of Assistant Secretary for Preparedness and Response3$14.3M

What Lovelace Biomedical Research Institute sells

Its awards by NAICS code. Codes with live notices link to them.

Contracts ending soon

Awards that end in the next 18 months, soonest first. Expiring work is often recompeted.

Largest awards

By total obligated value. Each links to its record on USAspending.gov.

AwardObligatedStartEnd
STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.

Food and Drug Administration · 75F40119C10161

$38.8MSep 26, 2019Jun 30, 2025
SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP).

Food and Drug Administration · 75F40125P00216

$7.1MSep 19, 2025Sep 29, 2027
RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])

Office of Assistant Secretary for Preparedness and Response · 75A50123F61001

$5.9MSep 29, 2023Apr 17, 2027
NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)

National Institutes of Health · 75N95020F00001

$5.3MSep 25, 2020May 31, 2027
DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD)

National Institutes of Health · 75N95019F00088

$5MJul 1, 2019Sep 30, 2024
PROJECT RTOR BIO-AMT-1021: DEVELOPMENT OF ANIMAL MODELS FOR EVALUATION OF MEDICAL COUNTERMEASURES FOR SARS-COV-2

Office of Assistant Secretary for Preparedness and Response · 75A50120F33002

$4.7MMar 30, 2020Aug 31, 2021
TASK ORDER 1 -TITLE: ARE REDUCTIONS IN BOE, BOPH, AND OTHER HEALTH RISK MARKERS PROPORTIONAL TO REDUCTIONS IN CIGARETTE SMOKING UPON SWITCHING TO ENDS

Food and Drug Administration · 75F40123F19001

$3.9MSep 27, 2023Apr 18, 2025
RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1

Office of Assistant Secretary for Preparedness and Response · 75A50126F61002

$3.7MAug 26, 2026Apr 25, 2028
NICOTINE FLUX: INVESTIGATING THE IMPACT OF ENDS OUTPUT POWER AND HEATING ELEMENT ON ABUSE LIABILITY

Food and Drug Administration · 75F40126F19003

$3MSep 14, 2026Sep 13, 2030
LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE: TO PERFORM NON-CLINICAL SAFETY ASSESSMENT OF TTHX1114 TO SUPPORT FUCHS ENDOTHELIAL CORNEAL DYSTROPHY IND APPLICATION.

National Institutes of Health · 75N95018F00002

$2.8MSep 17, 2018Oct 30, 2020
CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022

National Institutes of Health · 75N95020F00002

$2.3MSep 18, 2020Apr 28, 2025
EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PERIOD OF PERFORMANCE SEPTEMBER 25, 2020 - SEPTEMBER 24, 2022

National Institutes of Health · 75N95020F00005

$2.3MSep 25, 2020Jul 15, 2025

Similar contractors

Companies winning under the same main NAICS code.

ContractorAwardsObligated
Transportation Research Center Inc

UEI VM3RJUJSN3A4

57$154M
Ginkgo Bioworks, Inc.

UEI ZRHJUJQSBRA4

3$142M
Agile Defense, LLC

UEI KRGLGTXRYL94

50$119M
Raytheon Company

UEI VTEWM5QSE598

9$114M
The Broad Institute, Inc

UEI H5G9NWEFHXN4

8$111M
Emory University

UEI S352L5PJLMP8

10$94.6M

Stop checking this page by hand

Matched, not listed

Describe your company once. Captivaq scores every new notice against your capabilities, locations, and set-asides.

Earlier than the RFP

Forecasts and sources sought notices surface months before the solicitation, while you can still shape the win.

A draft, not a link

For the bids worth pursuing, it reads the solicitation and drafts the response with citations back to the source.

Build a matching profile

Questions people ask

What is Lovelace Biomedical Research Institute's UEI?

MBT9RXJJ7428. The Unique Entity ID is the 12-character number SAM.gov assigns to every company that registers to do business with the federal government. It replaced the DUNS number in 2022.

How much has Lovelace Biomedical Research Institute won in federal contracts?

$97.8M obligated across 20 awards in Captivaq's records, most of it from Food and Drug Administration. That covers contracts of $1M or more active since October 2023, so the full history is larger.

Which Lovelace Biomedical Research Institute contracts end soon?

6 awards end in the next 18 months, listed on this page. Expiring contracts are often recompeted, which is the opening for a competitor or a teaming partner.

Figures come from federal award records published on USAspending.gov: contracts of $1M or more active since October 2023, plus smaller awards tied to open opportunities. They are not a complete contract history; each award above links to its official record.

Captivaq is an independent service from Logesta Labs LLC and is not affiliated with or endorsed by the U.S. government or SAM.gov. The notice on the official source portal is the record that governs; confirm deadlines and amendments there.